• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

狼疮性肾炎肾组织病理活动指数非侵入性预测模型的开发与验证

Development and validation of non-invasive prediction models for assessing kidney histopathological activity index in lupus nephritis.

作者信息

Zhang Fan, Shan Ying, Jian Xinyao, Qi Miao, Wei Yanling, Guo Jialong, Hou Shuang, Shi Jianqing, Xiong Zibo, Huang Xiaoyan

机构信息

Department of Nephrology, Peking University Shenzhen Hospital, Shenzhen, Guangdong, 518036, China.

Clinical Research Academy, Peking University Shenzhen Hospital, Shenzhen, Guangdong, 518036, China.

出版信息

Clin Rheumatol. 2025 Feb;44(2):693-700. doi: 10.1007/s10067-024-07268-w. Epub 2024 Dec 20.

DOI:10.1007/s10067-024-07268-w
PMID:39704985
Abstract

OBJECTIVE

To develop and validate prediction models for estimating the activity index (AI) of kidney histopathology in lupus nephritis (LN) using clinical and laboratory data.

METHODS

This study used single-center data from patients with kidney biopsy-confirmed LN between January 2012 and March 2022. The development and validation datasets were temporally cut. We discriminated AI > 10 and ≤ 10 as high and mild/moderate activity status, respectively. We constructed four models for AI: Model 1 included demographic information; Model 2 additionally incorporated data of systemic conditions; Model 3 further included kidney-specific conditions; and Model 4 included all the aforementioned predictors. Logistic regression was employed in Models 1 to 3, while Model 4 utilized least absolute shrinkage and selection operator for predictor selection and model building. Internal validation was performed using 1000 bootstrap resampling, while external validation was performed in the temporal validation dataset. Both calibration and discrimination metrics were evaluated.

RESULTS

There were 160 patients in the development dataset and 70 patients in the validation dataset. In the temporal validation, all the models achieved acceptable calibration and excellent discrimination. Model 2 which contained relatively fewer predictors achieved the highest area under the receiver operator characteristic curve of 0.86 (95% confidence interval 0.76 to 0.94).

CONCLUSION

Our Model 2 incorporating demographic and systemic indicators exhibited good performance in estimating the AI of LN. We thus provide a simple yet effective algorithm to predict AI in patients with LN, potentially aiding clinicians in non-invasively assessing disease activity and guiding treatment decisions. Key Points • We developed a prediction model (Model 2) incorporating demographic and systemic indicators to predict AI in patients with LN. • The prediction model can aid clinicians in noninvasively assessing disease activity and guiding treatment decisions.

摘要

目的

利用临床和实验室数据开发并验证用于估计狼疮性肾炎(LN)肾脏组织病理学活动指数(AI)的预测模型。

方法

本研究使用了2012年1月至2022年3月期间经肾脏活检确诊为LN的患者的单中心数据。开发数据集和验证数据集按时间划分。我们将AI > 10和≤ 10分别判别为高活动状态和轻/中度活动状态。我们构建了四个用于AI的模型:模型1包括人口统计学信息;模型2额外纳入了全身状况数据;模型3进一步纳入了肾脏特异性状况;模型4包括所有上述预测因素。模型1至3采用逻辑回归,而模型4使用最小绝对收缩和选择算子进行预测因素选择和模型构建。内部验证采用1000次自助重采样,外部验证在时间验证数据集中进行。评估了校准和区分指标。

结果

开发数据集中有160例患者,验证数据集中有70例患者。在时间验证中,所有模型均实现了可接受的校准和出色的区分能力。包含相对较少预测因素的模型2在接受者操作特征曲线下的面积最高,为0.86(95%置信区间0.76至0.94)。

结论

我们纳入人口统计学和全身指标的模型2在估计LN的AI方面表现良好。因此,我们提供了一种简单而有效的算法来预测LN患者的AI,可能有助于临床医生无创评估疾病活动并指导治疗决策。要点 • 我们开发了一个纳入人口统计学和全身指标的预测模型(模型2)来预测LN患者的AI。 • 该预测模型可帮助临床医生无创评估疾病活动并指导治疗决策。

相似文献

1
Development and validation of non-invasive prediction models for assessing kidney histopathological activity index in lupus nephritis.狼疮性肾炎肾组织病理活动指数非侵入性预测模型的开发与验证
Clin Rheumatol. 2025 Feb;44(2):693-700. doi: 10.1007/s10067-024-07268-w. Epub 2024 Dec 20.
2
Development and validation of a nomogram for predicting the interstitial fibrosis and tubular atrophy in patients with lupus nephritis.狼疮性肾炎患者间质纤维化和肾小管萎缩预测列线图的开发与验证
Rheumatology (Oxford). 2025 May 1;64(5):2647-2655. doi: 10.1093/rheumatology/keae509.
3
A nomogram predicting the histologic activity of lupus nephritis from clinical parameters.基于临床参数预测狼疮肾炎组织学活动的列线图。
Nephrol Dial Transplant. 2024 Feb 28;39(3):520-530. doi: 10.1093/ndt/gfad191.
4
Prospective validation of a novel renal activity index of lupus nephritis.狼疮性肾炎新型肾脏活动指数的前瞻性验证
Lupus. 2017 Aug;26(9):927-936. doi: 10.1177/0961203316684212. Epub 2016 Dec 19.
5
A nomogram to predict the risk of proliferative lupus nephritis in patients with systemic lupus erythematosus involving the kidneys.用于预测累及肾脏的系统性红斑狼疮患者发生增殖性狼疮性肾炎风险的列线图。
Clin Immunol. 2024 Aug;265:110296. doi: 10.1016/j.clim.2024.110296. Epub 2024 Jun 22.
6
Clinical predictive model to estimate probability of remission in patients with lupus nephritis.用于估计狼疮肾炎患者缓解概率的临床预测模型。
Int Immunopharmacol. 2022 Sep;110:108966. doi: 10.1016/j.intimp.2022.108966. Epub 2022 Jun 25.
7
Validation cohort of a tool to predict proliferative histological class in lupus nephritis based on clinical and laboratory data: LUCAS Study (Lupus Nephritis Class Assessment System).基于临床和实验室数据预测狼疮性肾炎增殖性组织学类型工具的验证队列:LUCAS研究(狼疮性肾炎分类评估系统)
Lupus Sci Med. 2025 Apr 28;12(1):e001538. doi: 10.1136/lupus-2025-001538.
8
Urinary markers differentially associate with kidney inflammatory activity and chronicity measures in patients with lupus nephritis.尿标志物与狼疮肾炎患者肾脏炎症活动和慢性程度指标的相关性不同。
Lupus Sci Med. 2023 Jan;10(1). doi: 10.1136/lupus-2022-000747.
9
Machine learning models predicts risk of proliferative lupus nephritis.机器学习模型预测增生性狼疮肾炎的风险。
Front Immunol. 2024 Jun 11;15:1413569. doi: 10.3389/fimmu.2024.1413569. eCollection 2024.
10
Analysis of interleukin-17 and interleukin-23 for estimating disease activity and predicting the response to treatment in active lupus nephritis patients.分析白细胞介素-17 和白细胞介素-23 以评估疾病活动度并预测活动性狼疮肾炎患者的治疗反应。
Immunol Lett. 2019 Jun;210:33-39. doi: 10.1016/j.imlet.2019.04.002. Epub 2019 Apr 17.

本文引用的文献

1
A panel of urinary proteins predicts active lupus nephritis and response to rituximab treatment.一组尿蛋白可预测狼疮性肾炎的活动期和对利妥昔单抗治疗的反应。
Rheumatology (Oxford). 2021 Aug 2;60(8):3747-3759. doi: 10.1093/rheumatology/keaa851.
2
A Validation of the 2018 Revision of International Society of Nephrology/Renal Pathology Society Classification for Lupus Nephritis: A Cohort Study from China.2018 年国际肾脏病学会/肾脏病理学会修订版狼疮肾炎分类的验证:来自中国的队列研究。
Am J Nephrol. 2020;51(6):483-492. doi: 10.1159/000507213. Epub 2020 Apr 22.
3
Update on Lupus Nephritis: Core Curriculum 2020.
狼疮肾炎更新:2020 年核心课程。
Am J Kidney Dis. 2020 Aug;76(2):265-281. doi: 10.1053/j.ajkd.2019.10.017. Epub 2020 Mar 24.
4
Lupus nephritis.狼疮性肾炎。
Nat Rev Dis Primers. 2020 Jan 23;6(1):7. doi: 10.1038/s41572-019-0141-9.
5
A Predictive Model for Estimation Risk of Proliferative Lupus Nephritis.预测增生性狼疮肾炎风险的模型。
Chin Med J (Engl). 2018 Jun 5;131(11):1275-1281. doi: 10.4103/0366-6999.232809.
6
Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices.狼疮肾炎国际肾脏病学会/肾脏病理学会分类修订:定义的澄清,以及国立卫生研究院活动和慢性指数的修改。
Kidney Int. 2018 Apr;93(4):789-796. doi: 10.1016/j.kint.2017.11.023. Epub 2018 Feb 16.
7
Prospective validation of a novel renal activity index of lupus nephritis.狼疮性肾炎新型肾脏活动指数的前瞻性验证
Lupus. 2017 Aug;26(9):927-936. doi: 10.1177/0961203316684212. Epub 2016 Dec 19.
8
Lupus nephritis: When and how often to biopsy and what does it mean?狼疮性肾炎:何时及多久进行肾活检,其意义是什么?
J Autoimmun. 2016 Nov;74:27-40. doi: 10.1016/j.jaut.2016.06.006. Epub 2016 Jun 24.
9
Multiple imputation with multivariate imputation by chained equation (MICE) package.多变量链方程插补(MICE)包的多重插补。
Ann Transl Med. 2016 Jan;4(2):30. doi: 10.3978/j.issn.2305-5839.2015.12.63.
10
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement.透明报告个体预后或诊断的多变量预测模型(TRIPOD):TRIPOD 声明。
BMJ. 2015 Jan 7;350:g7594. doi: 10.1136/bmj.g7594.